A group of [[Metabolic Diseases]] that  **↓ secretion** or **↓ action** of **[[Insulin]]** → **[[Hyperglycaemia]]** → damage to other organs ([[Kidney]], [[Eyes]], [[Nervous System]], [[Blood Vessels]], etc.) → morbidity and death

# Diagnosis

![[Pasted image 20220227123903.png]]

## Glucose Level
- [[FPG]] -- **↑ 126 mg/dL**
- [[RBS]] or [[OGTT]] -- → **↑ 200 mg/dL** + classic signs of [[Hyperglycaemia]]
- [[Hb A1C]] -- **↑ 6.5%**

> Higher q this cut-off [[Retinopathy]] and other co-morbidity ↑ significantly

## Autoimmune Markers
To R/O type 1 DM; **[[C Peptide]] can be used** as well -- type 1 → ↓ C peptide

# Clinical Manifestation
[[Hyperglycaemia]] → 
- Exceed threshold of [[Kidney]] → **[[Glycosuria]]** → ↓ osmotic pressure → **[[Polyuria]]** → **[[Dehydration]]**
- ↓ [[Insulin]] → ↑ [[Metabolism of Proteins]] → **[[Weight Loss]]** and **[[Polyphagia]]** 

# Complication
- [[Hyperglycaemia]] → **Damage to multiple organs**; mostly stem from [[Blood Vessels]]
	- Macrovascular → **[[Atherosclerosis]]**, **[[Myocardial Infarction]]**, **[[Stroke]]**, and **[[Gangrene]]** at lower extremities
	- Microvascular → 
		- **[[Diabetic Retinopathy]]**
		- **[[Diabetic Nephropathy]]**
		- **[[Diabetic Neuropathy]]**
- ↑ [[Ketogenesis]] → **[[Diabetic Ketoacidosis]]** -- life-threatening, esp. in **type I**

> Others : [[Gastroparesis]], [[Diarrhoea]], [[Sexual Dysfunction]], Infection, [[Cataract]], [[Glaucoma]], [[Periodontitis]], etc.

---

# Type I
- 5-10% of DM pt. 
- Onset of **~20 y/o**
- Replacement [[Insulin]] is neces for survival

## Risk Factors
- **Genetic** -- esp at HLA locus
- **Environment** -- viral infection ([[Mumps]], [[Rubella]], [[Cytomegalovirus]], [[Coxsackie B Virus]]) 

## Pathogenesis
[[Autoimmune Diseases]] → **[[Insulitis]]** → ↓ [[β Cell]] → **↓ [[Insulin]] secretion** (insulin-deficiency) 

## Treatment

![[Pasted image 20220227172015.png]]

[[Insulin Analogs#Pre-mixed]] → **Basal-Bolus Insulin** -- both to maintain/mimicks basal and prandial level.
- **Intensive Regimen** -- injection **q meals**
- **Less-intensive Regimen** -- **bid** at **breakfast** and **dinner**

> Alternatively : [[Insulin Analogs#Infusion Devices]] and [[Insulin Analogs#Inhalation]]

---

# Type II
- **90-95%** of DM pt
- **Adult onset** → **40 y/o ↑**
- s/c [[Insulin]] replacement, d pt. and stage 

## Pathogenesis
**[[Insulin Resistance]]** → **↓ [[Glucose]] utilization** → [[Hyperglycaemia]] → **compensatory 落 [[β Cell]]** (**[[Hyperinsulinaemia]]**) → **deposition of [[Amylin]]** → destruction of [[β Cell]] → [[Insulin Insufficiency]] in the end

> [[Insulin Resistance]] starts at [[Adipocyte]] → ↑ [[Free Fatty Acid]], [[Adipokines]], etc. → worsen the condition

## Treatment
**[[Non-insulin Antidiabetic Drugs]]** -- esp. **[[Metformin]]** and
- [[GLP-1 Receptor Agonists]] / [[SGLT-2 Inhibitors]] -- ico ↑ risk of [[Atherosclerosis]], other CVS diseases, and [[Albuminuria]]
- [[Insulin Analogs]] -- ico [[Insulin Insufficiency]]

Adjunct drugs are considered based on goals
- **To minimize [[Hypoglycaemia]]**
	- [[DPP-4 Inhibitors]], [[GLP-1 Receptor Agonists]], or [[Thiazolidinediones|TZD]]
- **To ↑ [[Weight Loss]]** 
	- [[GLP-1 Receptor Agonists]] or [[SGLT-2 Inhibitors]]
- **To minimize cost**
	- [[Insulin Analogs]], **[[Sulfonylureas]]**, and **[[Thiazolidinediones]]**
	> Only SU and TZD are free in Thailand

## Goals
- Glycaemic control 
	- [[Hb A1C]] -- **↓ 7%** (or even better, 6.5%) **EXCEPT pt. c Hx of severe [[Hypoglycaemia]]** → **8%**
	- [[FPG]] -- **80-130 mg/dL**
- [[Blood Pressure]] -- **140/90 mmHg**

---

# Gestational
## Clinical Correlation
Mothernal [[Hyperglycaemia]] (also amino acids and lipids) → cross [[Placenta]] → **↑ fetal [[Insulin]]** →
- ↑ fetal **fat deposition** and **[[Glycogen]]** → **[[Macrosomia]]**
- Fetal [[Hypoglycaemia]], [[Polycythaemia]], [[Hypocalcaemia]], and [[Hyperbilirubinaemia]]